Patience Pays: Anti-CGRP Migraine Therapy Insights

Research Summary

A recent review in the journal Pain Management highlights the importance of patience when using anti-CGRP therapies for migraine, which are a promising alternative to traditional treatments. While clinical trials have shown that these therapies can significantly reduce migraine frequency within three months, real-world data reveals a different story for some patients. About one-third of individuals who don't see improvements in the first three months experience relief between three and six months, with more benefiting by 12 months. This suggests extending treatment duration may be crucial for maximizing benefits, as late responses may involve complex mechanisms like central desensitization.

Study Details

📄 Title: Late response to anti-CGRP therapy for migraine.

👥 Research Team: Marsico O, Lioi M, Trimboli M

📚 Published In: Pain Manag

📅 Publication Date: 2025 Aug 21

🔗 Read Study

⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.